Concord Drugs Ltd.

Concord Drugs Ltd. share price is ₹37.20 as of December 8, 2023, 03:25 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

The 52-week high and low of Concord Drugs Ltd. is ₹41.80 and ₹24.80 respectively as of December 8, 2023, 03:25 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

The PE ratio of Concord Drugs Ltd. is 22.60 as of December 10, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).

The trailing twelve month (TTM) PB ratio of Concord Drugs Ltd. is 1.10 as of December 10, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

The Upper Circuit of Concord Drugs Ltd. is ₹44.53. The Lower Circuit of Concord Drugs Ltd. is ₹29.69.

Concord Drugs Ltd. reported an ROE of 2.81% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Concord Drugs Ltd., Promoter held 52.1%, and the public held 47.9% of the total shares.

You can easily buy shares of Concord Drugs Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Concord Drugs Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.